1. Home
  2. BDRX vs VBNB Comparison

BDRX vs VBNB Comparison

Compare BDRX & VBNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

N/A

Current Price

$2.49

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

VBNB

VanEck BNB ETF Common Shares of Beneficial Interest

N/A

Current Price

$22.15

Market Cap

2.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BDRX
VBNB
Founded
2000
N/A
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BDRX
VBNB
Price
$2.49
$22.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.7K
986.0
Earning Date
09-12-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$21.15
52 Week High
$11.88
$23.36

Technical Indicators

Market Signals
Indicator
BDRX
VBNB
Relative Strength Index (RSI) 37.01 38.83
Support Level $2.22 $21.15
Resistance Level $3.68 N/A
Average True Range (ATR) 0.26 0.17
MACD -0.03 -0.03
Stochastic Oscillator 6.76 45.22

Price Performance

Historical Comparison
BDRX
VBNB

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: